| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2008 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.390 | None | 1.000 | 2 | 0 | 1994 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.380 | None | 1.000 | 2 | 0 | 1997 | 2008 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
group | 0.360 | None | 1.000 | 2 | 0 | 1996 | 2012 | ||||||||
|
tumor protein p63 | 0.362 | 0.769 | 1.00 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2004 | 2011 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2011 | 2018 | |||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2002 | 2012 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
group | 0.360 | None | 1.000 | 1 | 0 | 1998 | 2015 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2002 | 2014 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 2000 | 2017 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
group | 0.370 | None | 1.000 | 1 | 0 | 2002 | 2008 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.380 | None | 1.000 | 5 | 0 | 1986 | 2010 | ||||||||
|
mitogen-activated protein kinase 3 | 0.379 | 0.885 | 3.7E-02 |
|
group | 0.340 | None | 1.000 | 2 | 0 | 2002 | 2018 | ||||||||
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
group | 0.600 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
group | 0.400 | None | 1.000 | 3 | 0 | 1994 | 2012 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2004 | 2017 | ||||||||
|
heme oxygenase 1 | 0.381 | 0.923 | 9.7E-03 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2005 | 2008 | ||||||||
|
proliferating cell nuclear antigen | 0.382 | 0.846 | 0.98 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 1993 | 2019 | ||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
group | 0.600 | None | 1.000 | 1 | 0 | 2002 | 2009 | ||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
group | 0.320 | None | 0.750 | 2 | 0 | 2014 | 2018 | |||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
group | 0.370 | None | 1.000 | 1 | 0 | 1998 | 2016 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2009 | 2018 |